Dr. Lee G. Wilbur, MD

Dr. Wilbur practices at CHI St. Vincent Infirmary in Little Rock, Arkansas, part of CommonSpirit Health.

Dr. Wilbur's NPI, 1003925975, was assigned on August 30, 2006. Dr. Wilbur graduated from University of Kansas School of Med (KC/Wich/Sal) in 2000. Dr. Wilbur holds Arkansas license E8306.

Dr. Wilbur's primary practice is CHI St. Vincent Infirmary, at Two St Vincent Circle, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 552-3000. Dr. Wilbur also practices at Chi St Vincent Infirmary Medical Center, 2 St Vincent Cir, Little Rock, AR 72205.

Dr. Wilbur's primary practice is CHI St. Vincent Infirmary in Little Rock, Arkansas, part of CommonSpirit Health. The medical group on file is Shiloh Emergency Group PLLC. Dmand AI also links Dr. Wilbur to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wilbur practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Wilbur's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Wilbur's licenses on file in 2 states: Arkansas and Indiana.

CMS data shows 598 Medicare services from Dr. Wilbur across 4 procedure codes in 2024, for 378 Medicare patients. Medicare paid $50,141 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 378 Medicare patients who saw Dr. Wilbur in 2024. The largest group is 75 to 84, with 127 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wilbur's median patient age at 68, with 61% women.

In 2024, Dr. Wilbur wrote 216 Medicare Part D claims for 143 patients. 92% of them were for generic drugs. CMS names the drug for 67 of them, across 5 drugs with 11 or more claims each, at $503 in total drug cost. In 2023, CMS named 34 claims across 2 drugs.

Dmand AI links 20 papers to Dr. Wilbur, published from 2011 to 2019. 2011 was the busiest year, with 6. The most frequent topics are Emergency Service, Hospital, Mass Screening and Attitude of Health Personnel. Dr. Wilbur has published most often in Ann Emerg Med. Dr. Wilbur's most frequent co-authors are Rawle A. Seupaul, MD, John Philip Abraham, DO and Edward A. Bartkus, MD.

Dmand AI links Dr. Wilbur to 3 clinical trials. Conditions studied include COVID-19, Pneumonia, Viral and Severe Acute Respiratory Syndrome. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Wilbur that name 1 trial.

CMS Open Payments shows 5 general payments to Dr. Wilbur from 4 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 52% of the total. CSL Behring paid the most, $40. It also lists 2 research payments totaling $426 from 2020 to 2021, naming 1 clinical trial.

Dr. Wilbur graduated from University of Kansas School of Med (KC/Wich/Sal) in 2000.